Vera M. Todd

Vera M. Todd

Auto-generated profile, based on publicly available information

Vera M. Todd

Department of Medicine, Vanderbilt University Medical Center (VUMC), Nashville, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 April 2021 in Nature
Verified
Journal Article
Closed access
PDF file
BRBradley I. Reinfeld
Bradley I. Reinfeld
MMMatthew Z. Madden
Matthew Z. Madden
MWMelissa M. Wolf
Melissa M. Wolf
ACAnna Chytil
Anna Chytil
JBJackie E. Bader
Jackie E. Bader
WRW. Kimryn Rathmell
W. Kimryn Rathmell

1 October 2020 in Cancer Letters
Verified
Journal Article
Closed access
VTVera M. Todd
Vera M. Todd
RJRachelle Johnson
Rachelle Johnson

22 January 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DJDeborah Johnson
Deborah Johnson
KRKaylia M. Reynolds
Kaylia M. Reynolds
BPBrian Poole
Brian Poole
MMMatthew D. Montierth
Matthew D. Montierth
VTVera M. Todd
Vera M. Todd
MDMary Davis
Mary Davis
Patients with autoimmune disorders (AD) have altered cancer risks compared to the general population. Systemic lupus erythematosus and multiple sclerosis lead to a heightened risk for hematological malignancies and decreased risk for breast, ovarian, and prostate malignancies. Often patients with autoimmune disease have dysregulated antiviral immune responses, including against oncogenic viruses. To uncover the relationship between viral incidence and cancer risk in the context of autoimmune disease, we extracted electronic health records (EHR) from Vanderbilt University. ICD-9/10 codes and laboratory values were collected for hematological, lung, anal-vaginal, thyroid, hepatobiliary, bladder, prostate, and breast cancers; and viruses including Epstein Barr virus (EBV), Human papilloma virus (HPV), and Hepatitis A/B/C (Hep). Only viral infections that led to a physician visit or laboratory test were entered into the EMR; therefore, only clinically relevant cases were noted and considered positive in this study. The relationship between virus infection and cancer in an SLE cohort (SLE-cases n = 2,313, and SLE-controls n = 5,702) and an MS cohort (MS-case n = 7,277, MS-control n = 7,277) was examined by multilinear logistic regression. Viral infection was strongly associated with increased risk for cancer overall. SLE and MS patients were more susceptible to all viral infections. MS patients trended toward increased risk for cancers overall, while decreased risk for hormone-based cancers in SLE patients non-significantly reduced their risk for overall cancer. Both SLE and MS patients had increased clinically relevant EBV infection, which was associated with risk for hematological cancers. Preventing viral infections by vaccination may be especially helpful in controlling risk for cancer in SLE and MS patients.

10 August 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
BRBi Reinfeld
Bi Reinfeld
MMMatthew Z Madden
Matthew Z Madden
MWMelissa M Wolf
Melissa M Wolf
ACAnna Chytil
Anna Chytil
JBJe Bader
Je Bader
RBRachel E Brown
Rachel E Brown
The tumor microenvironment (TME) includes transformed cancer and infiltrating immune cells 1,2 . Cancer cells can consume large quantities of glucose through Warburg metabolism 3,4 that can be visualized with positron emission tomography (PET). While infiltrating immune cells also rely on glucose, disruptions to metabolism can contribute to tumor immunological evasion 5–9 . How immune cell metabolism is programmed or restrained by competition with cancer cells for nutrients, remains uncertain. Here we used PET tracers to measure the accessibility of glucose and glutamine to cell subsets in the TME. Surprisingly, myeloid cells including macrophages were the greatest consumers of intra-tumoral glucose, followed by T cells and cancer cells. Cancer cells, in contrast, had the highest glutamine uptake. This distinct nutrient partitioning was programmed through selective mTORC1 signaling and glucose or glutamine-related gene expression. Inhibition of glutamine uptake enhanced glucose uptake across tumor resident cell types and shifted macrophage phenotype, demonstrating glucose is not limiting in the TME. Thus, cancer cells are not the only cells in tumors which exhibit high glucose uptake in vivo and instead preferentially utilize glutamine over other cell types. We observe that intrinsic cellular programs can play a major role in the use of some nutrients. Together, these data argue cell selective partitioning of glucose and glutamine can be exploited to develop therapies and imaging strategies to alter the metabolic programs of specific cell populations in the TME.